Integrin Receptor Antagonists [MoA] - N0000175774

Pharmacologic Class Information

Pharmacologic Code N0000175774
Pharmacologic Name Integrin Receptor Antagonists
Pharmacologic Uses
  • integrin receptor antagonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Integrin Receptor Antagonists

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Integrin Receptor Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
64406-008Tysabri Non-Proprietary Name: NatalizumabInjectionIntravenousBiogen Inc.ACTIVE
64764-300Entyvio Non-Proprietary Name: VedolizumabInjection, Powder, Lyophilized, For SolutionIntravenousTakeda Pharmaceuticals America, Inc.ACTIVE